Neuroblastoma and the epigenome

IS Fetahu, S Taschner-Mandl - Cancer and Metastasis Reviews, 2021 - Springer
Neuroblastoma (NB) is a pediatric cancer of the sympathetic nervous system and one of the
most common solid tumors in infancy. Amplification of MYCN, copy number alterations …

Molecular mechanisms underlying autophagy-mediated treatment resistance in cancer

CJ Ho, SM Gorski - Cancers, 2019 - mdpi.com
Despite advances in diagnostic tools and therapeutic options, treatment resistance remains
a challenge for many cancer patients. Recent studies have found evidence that autophagy …

Vorinostat in autophagic cell death: A critical insight into autophagy-mediated,-associated and-dependent cell death for cancer prevention

S Patra, PP Praharaj, DJ Klionsky, SK Bhutia - Drug discovery today, 2022 - Elsevier
Histone deacetylases (HDACs) inhibit the acetylation of crucial autophagy genes, thereby
deregulating autophagy and autophagic cell death (ACD) and facilitating cancer cell …

Therapy resistance in neuroblastoma: Mechanisms and reversal strategies

X Zhou, X Wang, N Li, Y Guo, X Yang… - Frontiers in …, 2023 - frontiersin.org
Neuroblastoma is one of the most common pediatric solid tumors that threaten the health of
children, accounting for about 15% of childhood cancer-related mortality in the United …

Thioredoxin‐related protein of 14 kDa as a modulator of redox signalling pathways

B Espinosa, ESJ Arnér - British Journal of Pharmacology, 2019 - Wiley Online Library
Thioredoxin‐related protein of 14 kDa (TRP14; also named TXNDC17 for thioredoxin
domain‐containing protein 17) is a highly conserved and ubiquitously expressed …

Targeting cytoprotective autophagy to enhance anticancer therapies

M Xiao, A Benoit, M Hasmim, C Duhem, G Vogin… - Frontiers in …, 2021 - frontiersin.org
Autophagy is a highly regulated multi-step process that occurs at the basal level in almost all
cells. Although the deregulation of the autophagy process has been described in several …

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma

T Chen, C Zeng, Z Li, J Wang, F Sun, J Huang… - Frontiers in …, 2022 - frontiersin.org
High-risk neuroblastoma (NB) is sensitive to chemotherapy but susceptible to
chemoresistance. In this study, we aimed to analyze the incidence of chemoresistance in …

Beclin1 inhibition enhances paclitaxel-mediated cytotoxicity in breast cancer in vitro and in vivo

CL Wu, JF Liu, Y Liu, YX Wang… - International …, 2019 - spandidos-publications.com
Beclin1, a key regulator of autophagy, has been demonstrated to be associated with cancer
cell resistance to chemotherapy. Paclitaxel is a conventional chemotherapeutic drug used in …

[HTML][HTML] HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and in vivo antitumor efficacy of paclitaxel in an orthotopic brain tumor model

W Zeng, BYK Law, VKW Wong, DSB Chan… - Cancer Biology & …, 2020 - ncbi.nlm.nih.gov
Objective: Delivery of chemotherapeutic drugs to the brain has remained a major obstacle in
the treatment of glioma, owing to the presence of the blood-brain barrier and the activity of P …

Personalized medicine for neuroblastoma: Moving from static genotypes to dynamic simulations of drug response

JZR Han, JF Hastings, M Phimmachanh, D Fey… - Journal of personalized …, 2021 - mdpi.com
High-risk neuroblastoma is an aggressive childhood cancer that is characterized by high
rates of chemoresistance and frequent metastatic relapse. A number of studies have …